Therefore, the present study is aimed at elucidating the potential effect of a DPP-4 inhibitor on cardiovascular risk markers, foam cell formation in macrophages, and associated gene expression levels in macrophages isolated from diabetic db/db mice and T2D patients ex vivo. Here, DPP4 is linked to type 2 diabetes mellitus.